
Enlivex Therapeutics Ltd. ENLV
€ 0.91
-4.69%
Geschäftsbericht 2024
hinzugefügt 21.03.2026
Enlivex Therapeutics Ltd. Finanzkreislauf 2011-2026 | ENLV
Finanzkreislauf Jährlich Enlivex Therapeutics Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -193 | -106 | -18.4 | -368 | -1.03 K | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -18.4 | -1.03 K | -344 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Altimmune
ALT
|
7.85 K | $ 3.34 | -2.91 % | $ 294 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
205 | $ 19.2 | -0.18 % | $ 897 M | ||
|
Kamada Ltd.
KMDA
|
163 | $ 8.14 | -0.73 % | $ 260 M | ||
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.63 | - | $ 16.5 M | ||
|
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
Karyopharm Therapeutics
KPTI
|
72.5 | $ 6.19 | -7.06 % | $ 754 K | ||
|
Arbutus Biopharma Corporation
ABUS
|
50 | $ 4.29 | -2.94 % | $ 822 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Brickell Biotech
BBI
|
149 | - | -5.38 % | $ 6.06 M | ||
|
Kymera Therapeutics
KYMR
|
-46.6 | $ 74.44 | -3.27 % | $ 6.29 B | ||
|
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Cara Therapeutics
CARA
|
52.4 | - | -3.03 % | $ 260 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Завод ДИОД
DIOD
|
-32.7 | - | - | - |